- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/08 - Virus à ARN
Détention brevets de la classe C07K 14/08
Brevets de cette classe: 538
Historique des publications depuis 10 ans
|
34
|
27
|
30
|
31
|
37
|
51
|
44
|
54
|
44
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Realta Holdings, LLC | 29 |
11 |
| Boehringer Ingelheim Animal Health USA Inc. | 418 |
9 |
| The Regents of the University of California | 20720 |
8 |
| Children's Hospital Medical Center | 746 |
8 |
| Finncure Oy | 13 |
8 |
| Board of Regents, The University of Texas System | 6102 |
7 |
| The Trustees of Columbia University in the City of New York | 3643 |
7 |
| Folia Biotech Inc. | 10 |
7 |
| Intervet International B.V. | 1341 |
7 |
| Regents of the University of Minnesota | 2785 |
7 |
| Chengdu Kanghua Biological Products Co., Ltd. | 12 |
7 |
| Duke University | 3184 |
6 |
| The Scripps Research Institute | 1343 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
6 |
| University of Manitoba | 441 |
6 |
| Centre National de La Recherche Scientifique | 11016 |
5 |
| The Trustees of the University of Pennsylvania | 4414 |
5 |
| Medicago Inc. | 127 |
5 |
| Saiba Animal Health AG | 13 |
5 |
| Pfizer Inc. | 3384 |
4 |
| Autres propriétaires | 404 |